Finance

Beta
Lists
INBX:NASDAQ
Inhibrx Biosciences Inc
$104.01
+0.03%
(+0.030) 1D
$104.01
0.00% (0.00)
After hours
Closed: May 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INBX...
Open
$104.12
High
$105.41
Low
$101.37
Mkt. cap
1.53B
Avg. vol.
600.51K
Volume
245.15K
52-wk high
$155.29
52-wk low
$12.80
EPS
-$8.39
Shares outstanding
14.67M
No. of employees
110
Open
$104.12
High
$105.41
Low
$101.37
Mkt. cap
1.53B
Avg. vol.
600.51K
Volume
245.15K
52-wk high
$155.29
52-wk low
$12.80
EPS
-$8.39
Shares outstanding
14.67M
No. of employees
110
News stories
From sources across the web
About Inhibrx Biosciences Inc
CEO-
Employees110
Founded2024
HeadquartersLa Jolla, California, United States
SectorBiotechnology
Websiteinhibrx.com
Last report
May 14, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$2.15 / -$1.20
-79.17%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.30M
-
-
-
Cost of goods sold
22.27M
28.54M
25.35M
25.22M
Cost of revenue
22.27M
28.54M
25.35M
25.22M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.42M
5.28M
5.57M
5.71M
Operating expense
6.42M
5.28M
5.57M
5.71M
Total operating expenses
28.69M
33.81M
30.92M
30.93M
Operating income
-27.39M
-33.81M
-30.92M
-30.93M
Other non operating income
-246.00K
-46.00K
-39.00K
-12.00K
EBT including unusual items
-28.65M
-35.26M
-32.83M
-33.44M
EBT excluding unusual items
-28.65M
-35.26M
-32.83M
-33.44M
Income tax expense
2.00K
-
-
-
Effective tax rate
-0.01%
-
-
-
Other operating expenses
-
-
-
-
Net income
-28.65M
-35.26M
-32.83M
-33.44M
Net profit margin
-2,204.15%
-
-
-
Earnings per share
-1.85
-2.28
-2.11
-2.15
Interest and investment income
2.12M
1.78M
1.31M
1.01M
Interest expense
-3.14M
-3.18M
-3.18M
-3.51M
Net interest expenses
-1.02M
-1.40M
-1.87M
-2.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.73M
-33.23M
-30.36M
-30.39M
Gain or loss from assets sale
-
3.00K
9.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer